scispace - formally typeset
K

Kazuhiro Tateda

Researcher at Toho University

Publications -  61
Citations -  3058

Kazuhiro Tateda is an academic researcher from Toho University. The author has contributed to research in topics: Pseudomonas aeruginosa & Legionella pneumophila. The author has an hindex of 27, co-authored 61 publications receiving 2838 citations. Previous affiliations of Kazuhiro Tateda include University of Tokyo.

Papers
More filters
Journal ArticleDOI

Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophila infection

TL;DR: In this paper, the authors reported that mouse macrophages restricted Legionella pneumophila replication and initiated a proinfl ammatory program of cell death when fl agellin contaminated their cytosol.
Journal ArticleDOI

The Pseudomonas aeruginosa autoinducer N-3-oxododecanoyl homoserine lactone accelerates apoptosis in macrophages and neutrophils.

TL;DR: The data suggest that the quorum-sensing molecule 3-oxo-C12-HSL has critical roles in the pathogenesis of P. aeruginosa infection, not only in the induction of bacterial virulence factors but also in the modulation of host responses.
Journal ArticleDOI

Efficacy of Bacteriophage Therapy against Gut-Derived Sepsis Caused by Pseudomonas aeruginosa in Mice

TL;DR: It is suggested that oral administration of phage may be effective against gut-derived sepsis caused by P. aeruginosa, and the levels of inflammatory cytokines in blood and liver were significantly lower inphage-treated mice than in phage-untreated mice.
Journal ArticleDOI

Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection

TL;DR: It is indicated that the azithromycin treatment in vivo results in significant reduction in airway-specific inflammation, which occurs in part by inhibition of neutrophil recruitment to the lung through reduction in proinflammatory cytokine expression and inhibition ofNeutrophil migration via the extracellular signal-regulated kinase-1 and -2 signal transduction pathway.
Journal ArticleDOI

Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa

TL;DR: Data suggest that colistin may be an important option for combination therapy against critical MDRP infections, especially for pneumonia especially, and not only for synergistic antibacterial activity, but also for blocking LPS.